If you found morning semaglutide injections comfortable, you might find that retatrutide needs an evening shift during dose escalation but can return to morning timing at maintenance doses
Nauck MA, Duran S, Kim D, Johns D, Northrup J, Festa A, Brodows R & Trautmann ME
The Food and Drug Administration (FDA) has approved Eli Lillys Foundayo (orforglipron), a once-daily oral glucagon-like peptide-1 (GLP-1) receptor agonist, which offers a noninjectable option for weight management
This is especially important if you have type 2 diabetes, other long-term conditions, a history of significant gastrointestinal symptoms, or uncertainty about whether you actually meet obesity-treatment criteria in the first place
Q: Can I travel across state lines or internationally with GLP-1 medications
The most important factor is adherencechoosing a time that fits naturally into daily routines maximises treatment compliance and therapeutic benefit